Page last updated: 2024-09-05

sorafenib and rutin

sorafenib has been researched along with rutin in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(rutin)
Trials
(rutin)
Recent Studies (post-2010) (rutin)
6,5207305,2514,1052441,778

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)rutin (IC50)
Lysine-specific histone demethylase 1AHomo sapiens (human)2.16

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Alsaif, NA; Bakheit, AH; Wani, TA; Zargar, S1
Hu, J; Huang, L; Lan, H; Lv, Y; Shen, X; Zhang, G; Zhou, M; Zhu, Y1

Other Studies

2 other study(ies) available for sorafenib and rutin

ArticleYear
Multi-spectroscopic investigation, molecular docking and molecular dynamic simulation of competitive interactions between flavonoids (quercetin and rutin) and sorafenib for binding to human serum albumin.
    International journal of biological macromolecules, 2020, Dec-15, Volume: 165, Issue:Pt B

    Topics: Binding Sites; Circular Dichroism; Humans; Kinetics; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Quercetin; Rutin; Serum Albumin, Human; Sorafenib; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Thermodynamics

2020
Rutin attenuates Sorafenib-induced Chemoresistance and Autophagy in Hepatocellular Carcinoma by regulating BANCR/miRNA-590-5P/OLR1 Axis.
    International journal of biological sciences, 2021, Volume: 17, Issue:13

    Topics: Animals; Antineoplastic Agents; Autophagy; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; RNA, Long Noncoding; Rutin; Scavenger Receptors, Class E; Sorafenib; Xenograft Model Antitumor Assays

2021